RYLAZE

ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN · Jazz Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RYLAZE, covering 2021-06-30 to 2024-04-15. Get the full timeline:

Most recent: FDA Approved: RYLAZE — Supplemental Application (Jazz Pharmaceuticals, Inc.)